Skip to search formSkip to main contentSkip to account menu

Omnipaque

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Summary Background: This prospective study aimed to assess the extent of spread of dye in the epidural space and whether it would… 
Review
1993
Review
1993
Background and Objectives. The volume of epidural local anesthetic required to achieve a particular dermatomal sensory level… 
1990
1990
We reported 7 cases of drug eruption due to Iohexol (Omnipaque) which was nonionic X-ray contrast agent without severe adverse… 
1990
1990
Disseminated maculopapular eruption developed 5 to 6 days after the administration of Iohexol (Omnipaque) for the drip infusion… 
1989
1989
The low osmolar nonionic contrast medium Omnipaque was used in 5,339 consecutive coronary angiographies and serious complications… 
1988
1988
Contrast media occasionally produce ventricular fibrillation during coronary angiography. We compared the fibrillatory propensity… 
1985
1985
In order to assess the vascular clinical trial program of iohexol (Omnipaque) in Europe, the results from the first 49 vascular… 
1985
1985
In order to compare tolerability and radiographic properties of Omnipaque (iohexol) 350 mg I/ml and Urografin (sodium meglumine… 
1984
1984
The first experience with Omnipaque in arthrography of the knee in patients is reported. Forty arthrographies were performed…